ACT Capital Management LLC Takes Position in enVVeno Medical Corporation $NVNO

ACT Capital Management LLC bought a new stake in enVVeno Medical Corporation (NASDAQ:NVNO) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 115,000 shares of the company’s stock, valued at approximately $37,000. ACT Capital Management LLC owned 0.17% of enVVeno Medical at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in NVNO. Perceptive Advisors LLC purchased a new position in shares of enVVeno Medical in the second quarter valued at $5,127,000. CM Management LLC boosted its stake in shares of enVVeno Medical by 108.3% in the fourth quarter. CM Management LLC now owns 1,250,000 shares of the company’s stock valued at $401,000 after purchasing an additional 650,000 shares during the period. Kingdon Capital Management L.L.C. boosted its stake in shares of enVVeno Medical by 58.2% in the third quarter. Kingdon Capital Management L.L.C. now owns 1,359,261 shares of the company’s stock valued at $1,232,000 after purchasing an additional 500,000 shares during the period. Jane Street Group LLC boosted its stake in shares of enVVeno Medical by 149.2% in the fourth quarter. Jane Street Group LLC now owns 178,855 shares of the company’s stock valued at $57,000 after purchasing an additional 107,084 shares during the period. Finally, Creative Planning purchased a new position in shares of enVVeno Medical in the second quarter valued at $54,000. 34.71% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of enVVeno Medical from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce”.

enVVeno Medical Stock Performance

Shares of NASDAQ:NVNO opened at $10.20 on Thursday. enVVeno Medical Corporation has a 1-year low of $8.67 and a 1-year high of $196.70. The company’s fifty day moving average is $10.84 and its two-hundred day moving average is $11.10. The stock has a market capitalization of $6.83 million, a price-to-earnings ratio of -0.40 and a beta of 1.10.

enVVeno Medical (NASDAQ:NVNO) last released its quarterly earnings data on Thursday, May 7th. The company reported ($5.89) earnings per share for the quarter, topping analysts’ consensus estimates of ($8.40) by $2.51.

enVVeno Medical Profile

enVVeno Medical, Inc is a clinical‐stage medical device company focused on the development and commercialization of subcutaneous vascular access systems for patients requiring repeated or long‐term intravenous therapy. Through its proprietary Freedom® platform, the company aims to offer an implantable alternative to traditional peripherally inserted central catheters (PICCs) and external tunneled catheters, addressing complications such as infection risk, dislodgement and patient discomfort.

The company’s lead product candidate, the Freedom PICC System, consists of a low‐profile, subcutaneous port connected to a flexible catheter designed for peripheral insertion.